Related Experiment Video
Updated: Jun 15, 2026
Amide Hydrogen/Deuterium Exchange & MALDI-TOF Mass Spectrometry Analysis of Pak2 Activation
Published on: November 26, 2011
Mass spectrometry analysis of complexes formed by myotonic dystrophy protein kinase (DMPK)
Francesca Forner1, Sandra Furlan, Sergio Salvatori
1Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, D-82152 Martinsried, Germany.
Abstract:
Myotonic dystrophy type 1 (DM1) is caused by an expansion of CTG repeats at the 3'-UTR of the serine/threonine protein kinase DMPK. Expanded CTG repeats are toxic since they are transcribed into an RNA molecule which is then sequestered within the nucleus in the form of foci. RNA cytotoxicity is linked to the aberrant splicing of several developmentally regulated genes. DMPK transcripts undergo alternative splicing giving rise to many isoforms but do not seem to be involved in the splicing dysregulation of DM1. However, decreased levels of DMPK in DM1 patients and DMPK involvement in muscle weakness and cardiac dysfunction in animal models have been reported. The variability in phenotypic expression of DMPK together with its differential subcellular targeting, suggests that different splicing isoforms may be involved in different signalling pathways, possibly through DMPK-interacting proteins. To gain better insight into the DMPK function, we used mass spectrometry to identify proteins co-segregating with DMPK in soluble complexes isolated from high-speed supernatant of rat muscles. We carried out experiments with native DMPK to preserve the physiological stoichiometry with potential partners. DMPK-containing complexes were isolated and immuno-detected by non-denaturing electrophoresis, gel filtration, ionic-exchange chromatography and immunoprecipitation. DMPK peptides were identified by high-resolution mass spectrometry together with several putative DMPK-binding proteins, including several heat shock proteins such as HSP20/HSPB6, HSP60/CPN60, HSP70 and HSP90. We also obtained evidence of a direct interaction of DMPK with alphaB-crystallin/HSPB5 and HSP25/HSPB1.
Insights
Myotonic dystrophy type 1 (DM1) involves toxic RNA foci. This study identified heat shock proteins interacting with the involved DMPK protein, offering new insights into DM1 molecular mechanisms.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Myotonic dystrophy type 1 (DM1) is a genetic disorder caused by expanded CTG repeats in the DMPK gene.
- These repeats form toxic RNA foci, leading to aberrant splicing and cellular dysfunction.
- While DMPK's role in DM1 pathology is unclear, its altered levels and involvement in muscle/cardiac issues suggest importance.
Purpose of the Study:
- To investigate the function of the DMPK protein in DM1.
- To identify proteins that interact with DMPK in muscle tissue.
- To understand potential signaling pathways involving DMPK isoforms.
Main Methods:
- Proteomics approach using mass spectrometry to identify DMPK-interacting proteins.
- Isolation of native DMPK-containing complexes from rat muscle.
- Techniques included non-denaturing electrophoresis, gel filtration, ion-exchange chromatography, and immunoprecipitation.
Main Results:
- Identified several heat shock proteins (HSP20, HSP60, HSP70, HSP90) co-segregating with DMPK.
- Confirmed direct interaction between DMPK and alphaB-crystallin (HSPB5) and HSP25 (HSPB1).
- These findings suggest DMPK functions within complexes involving heat shock proteins.
Conclusions:
- DMPK interacts with various heat shock proteins in muscle tissue.
- These interactions may mediate DMPK's role in DM1 pathogenesis.
- Further research into these protein complexes could reveal therapeutic targets for DM1.
